Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05624398 · ClinicalTrials.gov registry record · NA
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
A NA study of Cataract and Glaucoma Open-Angle, sponsored by Vold Vision P.L.L.C.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05624398: Recruiting NA study of Cataract and Glaucoma Open-Angle, sponsored by Vold Vision P.L.L.C.
NCT05624398 is a NA study of Cataract and Glaucoma Open-Angle that is actively recruiting participants, run by Vold Vision P.L.L.C. The registered enrollment target is 25 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05624398, a NA study of Cataract and Glaucoma Open-Angle, is actively recruiting participants, sponsored by Vold Vision P.L.L.C.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a minimally invasive type of glaucoma surgery using a special type of stent to reduce eye pressure, with the goal of better glaucoma control and the reduction in the need for medications to control eye pressure.
Conditions Studied
Interventions
- DEVICE Vivity IOL
Study Locations (1)
Arkansas
- Vold Vision P.L.L.C. - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-12-07 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What NCT05624398 shows while recruiting
NCT05624398 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Vivity IOL is the first listed.
NCT05624398 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05624398 about?
NCT05624398 is a clinical study titled "Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery". This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a mi...
What is the current status of trial NCT05624398?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2022-12-07. Estimated completion is 2025-05-01.
What conditions does trial NCT05624398 study?
This clinical trial studies the following conditions: Cataract, Glaucoma Open-Angle.
What interventions are being tested in trial NCT05624398?
The interventions under investigation include: Vivity IOL (DEVICE).
Who is sponsoring clinical trial NCT05624398?
This trial is sponsored by Vold Vision P.L.L.C, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05624398 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05624398's enrollment target sits among peer trials
25 77th of 83 higher than 6 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
-
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI